| Title : The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial - Raskind_2004_Arch.Neurol_61_252 |
| Author(s) : Raskind MA , Peskind ER , Truyen L , Kershaw P , Damaraju CV |
| Ref : Archives of Neurology , 61 :252 , 2004 |
| Abstract : |
| PubMedSearch : Raskind_2004_Arch.Neurol_61_252 |
| PubMedID: 14967774 |
| Title : Update on Alzheimer drugs (galantamine) - Raskind_2003_Neurologist_9_235 |
| Author(s) : Raskind MA |
| Ref : Neurologist , 9 :235 , 2003 |
| Abstract : |
| PubMedSearch : Raskind_2003_Neurologist_9_235 |
| PubMedID: 12971834 |
| Title : Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging - Petrie_2001_Psychoneuroendocrinology_26_147 |
| Author(s) : Petrie EC , Peskind ER , Dobie DJ , Veith RC , Raskind MA |
| Ref : Psychoneuroendocrinology , 26 :147 , 2001 |
| Abstract : |
| PubMedSearch : Petrie_2001_Psychoneuroendocrinology_26_147 |
| PubMedID: 11087961 |
| Title : Alzheimer's disease and related disorders - Raskind_2001_Med.Clin.North.Am_85_803 |
| Author(s) : Raskind MA , Peskind ER |
| Ref : Med Clin North Am , 85 :803 , 2001 |
| Abstract : |
| PubMedSearch : Raskind_2001_Med.Clin.North.Am_85_803 |
| PubMedID: 11349485 |
| Title : Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group - Raskind_2000_Neurology_54_2261 |
| Author(s) : Raskind MA , Peskind ER , Wessel T , Yuan W |
| Ref : Neurology , 54 :2261 , 2000 |
| Abstract : |
| PubMedSearch : Raskind_2000_Neurology_54_2261 |
| PubMedID: 10881250 |
| Title : The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group - Raskind_1999_J.Clin.Psychiatry_60_318 |
| Author(s) : Raskind MA , Cyrus PA , Ruzicka BB , Gulanski BI |
| Ref : J Clin Psychiatry , 60 :318 , 1999 |
| Abstract : |
| PubMedSearch : Raskind_1999_J.Clin.Psychiatry_60_318 |
| PubMedID: 10362441 |
| Title : Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease - Raskind_1998_J.Clin.Psychiatry_9_28 |
| Author(s) : Raskind MA |
| Ref : J Clin Psychiatry , 9 :28 , 1998 |
| Abstract : |
| PubMedSearch : Raskind_1998_J.Clin.Psychiatry_9_28 |
| PubMedID: 9720484 |
| Title : Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease - Raskind_1997_Arch.Neurol_54_836 |
| Author(s) : Raskind MA , Sadowsky CH , Sigmund WR , Beitler PJ , Auster SB |
| Ref : Archives of Neurology , 54 :836 , 1997 |
| Abstract : |
| PubMedSearch : Raskind_1997_Arch.Neurol_54_836 |
| PubMedID: 9236571 |
| Title : Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender - Peskind_1996_Biol.Psychiat_40_61 |
| Author(s) : Peskind ER , Raskind MA , Wingerson D , Pascualy M , Thal LJ , Dobie DJ , Wilkinson CW |
| Ref : Biological Psychiatry , 40 :61 , 1996 |
| Abstract : |
| PubMedSearch : Peskind_1996_Biol.Psychiat_40_61 |
| PubMedID: 8780856 |
| Title : Lack of cholinergic regulation of vasopressin and norepinephrine responses to hypertonic saline in humans - Pascualy_1995_Psychoneuroendocrinology_20_679 |
| Author(s) : Pascualy M , Peskind ER , Wingerson D , van Belle G , Veith RC , Dorsa DM , Raskind MA |
| Ref : Psychoneuroendocrinology , 20 :679 , 1995 |
| Abstract : |
| PubMedSearch : Pascualy_1995_Psychoneuroendocrinology_20_679 |
| PubMedID: 8848515 |
| Title : Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma - Peskind_1995_Biol.Psychiat_38_532 |
| Author(s) : Peskind ER , Wingerson D , Pascualy M , Thal L , Veith RC , Dorsa DM , Bodenheimer S , Raskind MA |
| Ref : Biological Psychiatry , 38 :532 , 1995 |
| Abstract : |
| PubMedSearch : Peskind_1995_Biol.Psychiat_38_532 |
| PubMedID: 8562665 |